IN PARTNERSHIP
“By integrating with robust software and data analytical tools, WestRock’s innovative SMART packaging enables DAT capture of daily detailed Brian Sheridan, VP, Global Adherence & Clinicals, WestRock
References 1.
Sabaté E, ed. Adherence to Long-Term Therapies: Evidence for Action. Geneva, Switzerland. World Health Organization. 2003.
2. Tim Mathes, Dawid Pieper, Sunya-Lee Antoine,and Michaela Eikermann. 50% adherence of patients suffering chronic conditions – where is the evidence? Sci. 2012; 10: Doc16.
3. Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, De Geest S, Dobbels F, Lewek P, Urquhart J, Vrijens B; ABC project team. assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs. 2013 May;73(6):545-62. doi: 10.1007/s40265-013-0041-3. PMID: 23588595; PMCID: PMC3647098.
4. El Alili M, Vrijens B, Demonceau J, Evers SM, Hiligsmann M. A scoping review of studies comparing the medication event monitoring system (MEMS) with alternative methods for measuring medication adherence. Br J Clin Pharmacol. 2016 Jul;82(1):268-79. doi: 10.1111/bcp.12942. Epub 2016 2 May.
PMID: 27005306; PMCID: PMC4917812.
5. Barbara K Zedler et al. A pharmacoepidemiologic analysis of the impact of calendar packaging on adherence to self-administered medications for long-term use. Clin Ther. 2011 May;33(5):581-97. doi: 10.1016/
j.clinthera.2011.04.020.
6. Leon Dupclay et al. Real-wrld impact of reminder packaging on antihypertensive treatment adherence and persistence: Patient Preference & Adherence. 2012;6:499-507. doi: 10.2147/PPA.S31417. Epub 2012
7. Hayden B. Bosworth et al. Evaluation of a packaging approach to improve cholesterol medication adherence. Am J Manag Care. 2017 Sep 1;23(9):e280-e286.
8. Izzah Z, Zijp TR, Åberg C, Touw DJ, van Boven JFM. Electronic smart blister packages to monitor and support medication adherence: a usability study. Patient Prefer Adherence. 2022 Sep 13;16:2543-2558. doi: 10.2147/ PPA.S374685. PMID: 36124125; PMCID: PMC9482437.
9. Digitally enabled, patient-centric clinical trials: shifting the drug development paradigm. Clin Transl Sci. 2021; 14, 445–459; doi:10.1111/cts.12910.
Outsourcing in Clinical Trials Handbook | 85
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100
